GlassScriptPhysician profile
Harvey C Taub
NPI 1679523294
$208,122.46
in general payments reported to CMS, 2019-2025
65 companies · $63K in 2025
The $63K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,317 · 2020: $4,765 · 2021: $4,986 · 2022: $5,712 · 2023: $63K · 2024: $62K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $180K · Food and Beverage: $8,076 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $180,000.00 |
| Food and Beverage | $8,075.53 |
| Education | $267.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $183,359.27 | 2022-2025 | Nanoknife, Nanoknife |
| Laser Specialty Medical, LLC | $9,500.00 | 2019-2021 | |
| Astellas Pharma US INC | $1,233.25 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,105.86 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Myriad Genetic Laboratories, INC. | $1,088.93 | 2021-2024 | Prolaris |
| Pfizer INC. | $983.53 | 2019-2025 | |
| Procept Biorobotics Corporation | $821.42 | 2019-2025 | Aquabeam System |
| Medtronic, INC. | $740.66 | 2021-2025 | Interstim |
| Abbvie INC. | $722.21 | 2019-2025 | Lupron Depot, Botox |
| Bayer Healthcare Pharmaceuticals INC. | $676.13 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $581.47 | 2019-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $573.02 | 2023-2025 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $472.36 | 2020-2022 | |
| Teleflex LLC | $457.67 | 2021-2025 | Barrigel, Solesta, Urolift |
| Endo Pharmaceuticals INC. | $437.31 | 2019-2024 | Aveed, Xiaflex |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $383.00 | 2021-2022 | |
| Coloplast Corp | $350.42 | 2019-2022 | |
| Telix Pharmaceuticals | $327.61 | 2022-2025 | Illuccix |
| Axonics, INC. | $321.37 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $302.21 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Novartis Pharmaceuticals Corporation | $278.13 | 2022-2025 | |
| Profound Medical Corp. | $225.11 | 2023-2025 | Tulsa-Pro |
| Urovant Sciences INC | $207.94 | 2021-2022 | |
| Urogen Pharma, INC. | $201.36 | 2020-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $199.81 | 2021-2025 | Provenge |
| Blue Earth Diagnostics | $184.01 | 2021-2025 | Posluma |
| Bioprotect Medical, INC. | $172.18 | 2024-2025 | Bioprotect Balloon Implant System |
| Caldera Medical, INC | $166.99 | 2023 | Desara |
| Merck Sharp & Dohme LLC | $146.16 | 2021-2025 | Keytruda, Lynparza |
| Tolmar Pharmaceuticals, INC. | $142.00 | 2019-2022 | |
| Sn Holdings, LLC | $140.00 | 2022 | |
| Cook Medical LLC | $135.76 | 2019 | |
| Tolmar, INC. | $128.92 | 2023-2025 | Eligard, Jatenzo |
| Accord Healthcare, INC. | $115.07 | 2022-2025 | |
| Endo USA, INC. | $108.48 | 2024-2025 | Xiaflex |
| Verity Pharmaceuticals INC. | $94.38 | 2022-2025 | Trelstar |
| Agiliti Surgical, INC. | $92.95 | 2023 | Sonablate, Greenlight Xps |
| Intuitive Surgical, INC. | $89.01 | 2023 | Da Vinci Surgical System |
| Allergan, INC. | $82.11 | 2019-2022 | |
| Dentsply Ih INC. | $79.15 | 2019-2021 | |
| Integra Lifesciences Corporation | $77.58 | 2021 | |
| Olympus America INC. | $71.02 | 2019-2023 | Itind System |
| 180 Medical, INC. | $67.29 | 2020-2021 | |
| Amgen INC. | $45.10 | 2020-2022 | |
| Smith+Nephew, INC. | $35.70 | 2019-2023 | Grafix Pl |
| Laborie Medical Technologies Corp. | $33.33 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Pacira Pharmaceuticals Incorporated | $29.17 | 2019 | |
| Immunitybio, INC. | $28.64 | 2024 | |
| Photocure INC | $25.51 | 2024 | Cysview |
| Alnylam Pharmaceuticals INC. | $24.17 | 2021 | |
| Sun Pharmaceutical Industries INC. | $24.16 | 2024 | |
| Rochester Medical Corporation | $23.43 | 2021 | |
| Acerus Pharmaceuticals Corporation | $23.21 | 2020-2022 | |
| Foundation Medicine, INC. | $21.89 | 2020 | |
| Valencia Technologies Corporation | $21.10 | 2025 | Ecoin Device Kit |
| Baxter Healthcare | $20.02 | 2021 | |
| Progenics Pharmaceuticals, INC. | $19.54 | 2025 | |
| Becton, Dickinson and Company | $18.44 | 2025 | Bard Urinary Drainage Bag |
| Azurity Pharmaceuticals, INC. | $16.07 | 2025 | Azmiro |
| Travere Therapeutics, INC. | $15.67 | 2020 | |
| Cardinal Health 414 LLC | $14.94 | 2025 | |
| Convatec INC. | $14.62 | 2022 | |
| Metuchen Pharmaceuticals | $12.89 | 2019 | |
| Neotract INC. | $11.75 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$136,647.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.